Can GLP-1s Slow Aging?
New research unveiled by drug makers says yes The post Can GLP-1s Slow Aging? appeared first on Nautilus .
Recent research suggests that GLP-1 medications, originally developed to aid weight loss, may also have significant anti-aging benefits. Companies Eli Lilly and Novo Nordisk, which produce tirzepatide and semaglutide respectively, claim their drugs are linked to a reduction in biological age, measured by molecular clocks. A study presented at the 13th annual Aging Research & Drug Discovery conference found that individuals using these drugs had molecular ages up to three years younger than those who took placebos alone.
Furthermore, measures of proteins related to heart health showed a four-year reduction in age. However, the data has not yet been independently verified or peer-reviewed, and the trials were conducted on overweight and diabetic individuals, not healthy adults. While the potential for these drugs to extend lifespans is promising, GLP-1s also come with side effects, such as muscle loss, which could pose additional health challenges. Further research, ideally conducted by unbiased parties, is needed to confirm these findings.
Written by urgent.news from Nautilus's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
